These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37888134)

  • 1. Assessing the Potential Risks of Digital Therapeutics (DTX): The DTX Risk Assessment Canvas.
    Denecke K; May R; Gabarron E; Lopez-Campos GH
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success Factors for Scaling Up the Adoption of Digital Therapeutics Towards the Realization of P5 Medicine.
    Prodan A; Deimel L; Ahlqvist J; Birov S; Thiel R; Toivanen M; Kolitsi Z; Kalra D
    Front Med (Lausanne); 2022; 9():854665. PubMed ID: 35492346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative interview study of patients' attitudes towards and intention to use digital interventions for depressive disorders on prescription.
    Posselt J; Baumann E; Dierks ML
    Front Digit Health; 2024; 6():1275569. PubMed ID: 38375490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the potential of digital therapeutics: An assessment of progress and promise.
    Armeni P; Polat I; De Rossi LM; Diaferia L; Meregalli S; Gatti A
    Digit Health; 2024; 10():20552076241277441. PubMed ID: 39291152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Digital Therapeutics Real-World Evidence Framework: An Approach for Guiding Evidence-Based Digital Therapeutics Design, Development, Testing, and Monitoring.
    Kim M; Patrick K; Nebeker C; Godino J; Stein S; Klasnja P; Perski O; Viglione C; Coleman A; Hekler E
    J Med Internet Res; 2024 Mar; 26():e49208. PubMed ID: 38441954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMCP Partnership Forum: The evolving role of digital therapeutics.
    J Manag Care Spec Pharm; 2022 Jul; 28(7):804-810. PubMed ID: 35699389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Therapies (DTx) as New Tools within Physicians' Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use.
    Bélisle-Pipon JC; David PM
    Pharmaceut Med; 2023 Mar; 37(2):121-127. PubMed ID: 36653600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges With the Use of Digital Sham: Systematic Review and Recommendations.
    Bos E; Preller KH; Kaur G; Malhotra P; Kharawala S; Motti D
    J Med Internet Res; 2023 Oct; 25():e44764. PubMed ID: 37874638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stakeholders' Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study.
    Sim B; Ju JH; Kim B; Lee JY
    JMIR Mhealth Uhealth; 2023 Oct; 11():e47407. PubMed ID: 37933414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMCP Partnership Forum: Digital Therapeutics-What Are They and Where Do They Fit in Pharmacy and Medical Benefits?
    J Manag Care Spec Pharm; 2020 May; 26(5):674-681. PubMed ID: 32175784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content.
    Lutz J; Offidani E; Taraboanta L; Lakhan SE; Campellone TR
    Front Digit Health; 2022; 4():823977. PubMed ID: 36060538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary glycation compounds - implications for human health.
    Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A
    Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis.
    Adu-Brimpong J; Pugh J; Darko DA; Shieh L
    J Med Internet Res; 2023 Aug; 25():e37447. PubMed ID: 37531157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Evaluation Associated With Clinical-Grade Mobile App-Based Digital Therapeutic Interventions: Systematic Review.
    Sapanel Y; Tadeo X; Brenna CTA; Remus A; Koerber F; Cloutier LM; Tremblay G; Blasiak A; Hardesty CL; Yoong J; Ho D
    J Med Internet Res; 2023 Aug; 25():e47094. PubMed ID: 37526973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.